2011

1-20 of 178 < first | prev | | last >
  • News: Forbes Ranks the Best Big Drug Companies of 2011

    Pfizer, Abbott Laboratories, and Eli Lilly all managed to notch share price increases of greater than 15%. So did Amgen, which continued to define the border between the biotechnology companies and big pharma, which it looks a bit more like every single year. But which drug company did Forbes rate the best?

    12/28/2011
  • News: GAO Report Blames Drug Shortages On Manufacturing Problems

    “Manufacturing problems were the primary cause of most shortages,” says an analysis by the Government Accountability Office. And how to fix this problem? The GAO’s answer is in its title: “Drug Shortages: FDA’s Ability to Respond Should be Strengthened.” WSJ reports.

    12/15/2011
  • Chinese Pharma Espionage? Targets Include Pfizer, Abbott, Boston Scientific

    "China has made industrial espionage an integral part of its economic policy, stealing company secrets to help it leapfrog over U.S. and other foreign competitors to further its goal of becoming the world's largest economy, U.S. intelligence officials have concluded in a report released last month" BusinessWeek and In the Pipeline report.

    12/15/2011
  • News: Who Is the Worst Biotech CEO of 2011?

    A desperate, $11 billion Hail Mary acquisition, two botched drug launches, a clueless, tin-eared investor relations strategy, and an expensive and quixotic quest to develop a product no one needs -- these are the transgressions that have earned five executives the dishonor of being nominated for TheStreet's Worst Biotech CEO of 2011 Award

    12/01/2011
  • News: Ben Venue Halts All Production at Ohio Plant

    A troubled contract manufacturer, whose problems caused a shortage of Johnson & Johnson's cancer drug Doxil, has suspended manufacturing and distribution of products from its Ohio plant, saying routine preventive maintenance and other required actions were overdue.

    11/28/2011
  • News: Swiss Doctor Boycotts Novartis Over Job Cuts

    A Geneva-based rheumatologist has said he will no longer prescribe Novartis medicines to patients in protest at job losses at the pharmaceutical company, which plans to shutter its production operations in the south-west of the country.

    11/10/2011
  • News: Teva Fires 1,500 Cephalon Workers

    Layoffs part of integration of Cephalon's activity into Teva, which is slated to hold $5 billion placement to finance acquisition of brand drugmaker.

    11/10/2011
  • News: What Bill Gates Says About Drug Companies

    Over the past decade, Gates has relied on giants like Merck, Pfizer, and Sanofi-Aventis to provide the vaccines that are a lynchpin of his charitable work. Check out his unique and thoughtful perspective on the pharma industry.

    11/10/2011
  • Is GSK CEO Andrew Witty On the List to Be Knighted?

    As the calendar year draws to a close, the UK government is busy readying the next list of individuals who are to be honored as members of the Order of the British Empire.The list, however, is a closely guarded secret. But one name that may be under consideration is Andrew Witty, the ceo at GlaxoSmithKline. Pharmalot reports.

    11/10/2011
  • News from ISPE Annual Meeting: MedImmune Named Facility of the Year

    ISPE, a global not-for-profit association of 22,000 pharmaceutical science and manufacturing professionals, announced during the Keynote Session at its 2011 Annual Meeting in Grapevine, Texas, USA, that MedImmune’s Frederick Manufacturing Center (FMC) Expansion Facility is the Overall Winner of the 2011 Facility of the Year Awards (FOYA) program.

    11/09/2011
  • Amgen To Lay Off 400 Employees

    A short while ago we wrote how Amgen hired away an exec from Bristol-Myers Squibb as part of its reorganization. Well, some additional news is now coming in and the biotech is eliminating several hundreds of jobs from its workforce, which currently number about 17,600 worldwide.

    10/20/2011
1-20 of 178 < first | prev | | last >